2014
Gender and Stress in Predicting Depressive Symptoms Following Stroke
Mazure CM, Weinberger AH, Pittman B, Sibon I, Swendsen J. Gender and Stress in Predicting Depressive Symptoms Following Stroke. Cerebrovascular Diseases 2014, 38: 240-246. PMID: 25401293, PMCID: PMC4283501, DOI: 10.1159/000365838.Peer-Reviewed Original ResearchConceptsPost-stroke depressionPost-stroke patientsDepressive symptomsStressful life eventsClinic visitsElectronic momentary assessmentRisk of PSDThree monthsLife eventsStandardized depression scalesRegular clinic visitsSpecific depressive symptomsStandard clinical assessmentPredicting Depressive SymptomsStroke centersAppetite changesProspective studyFunctional outcomeClinical assessmentDepression ScaleDepression assessmentGender differencesAmbulatory monitoringSignificant associationSymptoms
1998
Pretreatment plasma HVA predicts neuroleptic response in manic psychosis
Mazure C, Bowers M. Pretreatment plasma HVA predicts neuroleptic response in manic psychosis. Journal Of Affective Disorders 1998, 48: 83-86. PMID: 9495606, DOI: 10.1016/s0165-0327(97)00159-6.Peer-Reviewed Original Research
1991
Plasma free homovanillic acid (HVA) as a predictor of clinical response in acute psychosis
Mazure C, Nelson J, Jatlow P, Bowers M. Plasma free homovanillic acid (HVA) as a predictor of clinical response in acute psychosis. Biological Psychiatry 1991, 30: 475-482. PMID: 1932395, DOI: 10.1016/0006-3223(91)90309-a.Peer-Reviewed Original ResearchMeSH KeywordsAcute DiseaseAdolescentAdultBipolar DisorderChromatography, High Pressure LiquidDepressive DisorderDose-Response Relationship, DrugDrug Administration ScheduleFemaleFollow-Up StudiesHomovanillic AcidHumansMaleMethoxyhydroxyphenylglycolMiddle AgedPerphenazinePrognosisProspective StudiesPsychiatric Status Rating ScalesPsychotic DisordersSchizophreniaSchizophrenic PsychologyConceptsPlasma homovanillic acidHomovanillic acidFree homovanillic acidClinical responseEarly clinical responsePlasma-free homovanillic acidUseful clinical predictorClinical predictorsNeuroleptic treatmentAcute psychosisDopamine metabolismNoradrenergic functioningMethoxyhydroxyphenylglycolFavorable responsePsychotic inpatientsGood responseSignificant decline